Peripheral pain-sensing pathways

Peripheral pain-sensing pathways, or nociception, encompass the physiological processes by which noxious stimuli are detected and transmitted from the periphery to the central nervous system (StatPearls, 2023 [1]). This system relies on specialized sensory neurons called nociceptors, which express a variety of ion channels and receptors that transduce mechanical, thermal, and chemical energy into electrical signals (NIH, 2021 [2]). Key molecular components within these pathways include voltage-gated sodium channels (e.g., Nav1.7, Nav1.8), transient receptor potential (TRP) channels (e.g., TRPV1), and various G protein-coupled receptors (UniProt, 2024 [3, 4]). These signals travel via A-delta and C fibers to the spinal cord's dorsal horn, where they undergo initial processing before ascending to the brain (StatPearls, 2023 [1]). Chronic pain conditions often involve the sensitization of these pathways, leading to hyperalgesia and allodynia (Nature Reviews Disease Primers, 2017 [5]). Pharmacological management typically involves targeting specific nodes within these pathways to interrupt pain signaling and provide relief (PubChem, 2024 [6]).

Other names

NociceptionPeripheral nociceptive systemPain transmission pathwaysNociceptive signalingPeripheral pain pathways

Drugs targeting these pathways act through various mechanisms, including the blockade of voltage-gated sodium channels (e.g., Lidocaine), activation and subsequent desensitization of TRPV1 channels (e.g., Capsaicin), inhibition of cyclooxygenase enzymes to reduce prostaglandin synthesis (e.g., NSAIDs), and modulation of voltage-gated calcium channels to reduce neurotransmitter release (e.g., Gabapentinoids) (StatPearls, 2023; PubChem, 2024).